Oxiquim S.A. (SNSE:OXIQUIM)
Chile · Delayed Price · Currency is CLP 12,441
0.00 (0.00%)
At close: Jun 10, 2026
Oxiquim Income Statement
Financials in millions CLP. Fiscal year is January - December.
Millions CLP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 227,729 | 236,760 | 235,354 | 214,649 | 264,695 | 191,128 | |
Revenue Growth (YoY) | -5.36% | 0.60% | 9.65% | -18.91% | 38.49% | 20.86% |
Cost of Revenue | 153,786 | 160,730 | 156,020 | 143,688 | 186,748 | 129,836 |
Gross Profit | 73,943 | 76,030 | 79,334 | 70,961 | 77,948 | 61,291 |
Selling, General & Admin | 44,722 | 44,968 | 44,460 | 41,921 | 42,902 | 33,870 |
Other Operating Expenses | 1,134 | 1,130 | 879.29 | 903.63 | 904.64 | 590.69 |
Operating Expenses | 45,856 | 46,098 | 45,339 | 42,825 | 43,807 | 34,461 |
Operating Income | 28,087 | 29,933 | 33,994 | 28,136 | 34,141 | 26,830 |
Interest Expense | -2,466 | -2,542 | -2,375 | -2,755 | -2,440 | -1,611 |
Interest & Investment Income | 4,285 | 4,285 | 4,172 | 4,287 | 3,754 | 2,972 |
Currency Exchange Gain (Loss) | -731.42 | -86.79 | -2,304 | -244.04 | -2,382 | -2,357 |
Other Non Operating Income (Expenses) | 1,427 | 1,779 | 1,765 | 2,351 | 4,329 | 1,419 |
EBT Excluding Unusual Items | 30,601 | 33,367 | 35,252 | 31,776 | 37,403 | 27,253 |
Gain (Loss) on Sale of Assets | -1.64 | -1.64 | -6.89 | -159.2 | -42.97 | -5.98 |
Asset Writedown | 10 | 10 | -0.44 | - | 12.93 | 5.04 |
Other Unusual Items | -35.51 | -35.51 | -33.27 | -35.01 | -35.09 | -32.54 |
Pretax Income | 30,590 | 33,356 | 35,389 | 31,608 | 37,392 | 27,252 |
Income Tax Expense | 6,828 | 7,268 | 9,071 | 7,712 | 8,139 | 6,525 |
Earnings From Continuing Operations | 23,762 | 26,088 | 26,318 | 23,896 | 29,252 | 20,727 |
Earnings From Discontinued Operations | - | - | - | - | -192.19 | -25.34 |
Net Income | 23,762 | 26,088 | 26,318 | 23,896 | 29,060 | 20,702 |
Net Income to Common | 23,762 | 26,088 | 26,318 | 23,896 | 29,060 | 20,702 |
Net Income Growth | -12.67% | -0.87% | 10.13% | -17.77% | 40.38% | 20.23% |
Shares Outstanding (Basic) | 25 | 25 | 25 | 25 | 25 | 25 |
Shares Outstanding (Diluted) | 25 | 25 | 25 | 25 | 25 | 25 |
Shares Change (YoY) | 0.01% | -0.00% | 0.00% | - | -0.00% | 0.08% |
EPS (Basic) | 954.79 | 1048.30 | 1057.50 | 960.20 | 1167.71 | 831.80 |
EPS (Diluted) | 954.79 | 1048.30 | 1057.50 | 960.20 | 1167.71 | 831.80 |
EPS Growth | -12.68% | -0.87% | 10.13% | -17.77% | 40.38% | 20.13% |
Free Cash Flow | 20,460 | 22,947 | 18,848 | 26,409 | 3,446 | 10,523 |
Free Cash Flow Per Share | 822.11 | 922.08 | 757.35 | 1061.18 | 138.48 | 422.83 |
Dividend Per Share | - | - | 362.000 | 663.000 | 603.000 | 401.000 |
Dividend Growth | - | - | -45.40% | 9.95% | 50.37% | -28.39% |
Gross Margin | 32.47% | 32.11% | 33.71% | 33.06% | 29.45% | 32.07% |
Operating Margin | 12.33% | 12.64% | 14.44% | 13.11% | 12.90% | 14.04% |
Profit Margin | 10.44% | 11.02% | 11.18% | 11.13% | 10.98% | 10.83% |
Free Cash Flow Margin | 8.98% | 9.69% | 8.01% | 12.30% | 1.30% | 5.51% |
EBITDA | 37,879 | 39,498 | 42,776 | 34,346 | 38,532 | 30,479 |
EBITDA Margin | 16.63% | 16.68% | 18.18% | 16.00% | 14.56% | 15.95% |
D&A For EBITDA | 9,792 | 9,566 | 8,781 | 6,210 | 4,391 | 3,648 |
EBIT | 28,087 | 29,933 | 33,994 | 28,136 | 34,141 | 26,830 |
EBIT Margin | 12.33% | 12.64% | 14.44% | 13.11% | 12.90% | 14.04% |
Effective Tax Rate | 22.32% | 21.79% | 25.63% | 24.40% | 21.77% | 23.95% |